Procyon Advisors’s Evolent Health EVH Stock Holding History

Procyon Advisors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-424	Closed	-$2K	–	1101
2020 Q1	$2K	Hold	424	–	–	﹤0.01%	842
2019 Q4	$4K	Buy	+424	New	+$3.44K	﹤0.01%	827

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Procyon Advisors's EVH Position: Q2 2020 in Review

Procyon Advisors sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 424 shares — an estimated $2K sold.

Procyon Advisors first reported a position in EVH in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

Procyon Advisors reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
Procyon Advisors sold 424 Evolent Health shares in Q2 2020, an estimated $2K.
Procyon Advisors first reported a position in Evolent Health in Q4 2019 and held it in 2 quarters.
Procyon Advisors's Evolent Health position peaked at $4K in Q4 2019.
136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Procyon Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.